2025 Disease Nuclear Medicine 
Imaging Technology
NOVEMBER 7, 2024
Under the new policy, CMS will unpackage and pay separately for diagnostic radiopharmaceuticals with per-day costs exceeding $630, removing financial barriers that have long hindered patient access to essential nuclear medicine diagnostic procedures.
AuntMinnie
JULY 10, 2024
Currently, the CMS bundles Medicare payments for PET radiotracers for diagnosing disease as part of the packaged cost of imaging procedures in hospital outpatient settings. The association will be working with all stakeholders in support of the proposal before it is finalized at the beginning in 2025, Hope added.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
AuntMinnie
SEPTEMBER 25, 2024
Nuclear cardiologists could see significant reductions in Medicare reimbursements in 2025, according to a leading expert. million coronary artery disease procedures per year. Despite a proposal by the U.S. We would see a drop of approximately 3% in the reimbursement per SPECT study performed,” he said.
AuntMinnie
JULY 10, 2024
Currently, the CMS bundles Medicare payments for PET radiotracers for diagnosing disease as part of the packaged cost of imaging procedures in hospital outpatient settings. The association will be working with all stakeholders in support of the proposal before it is finalized at the beginning in 2025, Hope added.
AuntMinnie
OCTOBER 2, 2024
Ultrasound model predicts liver disease progression. Bodien, et al, New England Journal of Medicine , August 14, 2024. Commercially Available Chest Radiograph AI Tools for Detecting Airspace Disease, Pneumothorax, and Pleural Effusion. Luthria, et al, Journal of Nuclear Medicine , October 26, 2023.
Imaging Technology
NOVEMBER 1, 2024
We also expect to see the full Phase 1 results presented at a scientific meeting in 2025." "The Front loading radioactivity and extending the time on therapy may lengthen time to disease progression. Journal of Nuclear Medicine (2024). We will explore these concepts in Phase 2.
Imaging Technology
JANUARY 5, 2024
milla1cf Fri, 01/05/2024 - 11:32 January 5, 2024 — NorthStar Medical Radioisotopes, LLC , a global innovator in development, production and commercialization of radiopharmaceuticals used to detect and treat cancer and other serious diseases, and Curadh MTR Inc.
Expert insights. Personalized for you.
97 
Let's personalize your content